• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

A new role for C-1-inhibitor in homeostasis: control of activation of the first component of human complement.

作者信息

Ziccardi R J

出版信息

J Immunol. 1982 Jun;128(6):2505-8.

PMID:7077078
Abstract
摘要

相似文献

1
A new role for C-1-inhibitor in homeostasis: control of activation of the first component of human complement.C1抑制剂在体内平衡中的新作用：对人类补体第一成分激活的控制
J Immunol. 1982 Jun;128(6):2505-8.
2
A mechanism for the spontaneous activation of the first component of complement, C1, and its regulation by C1-inhibitor.
J Immunol. 1988 Dec 1;141(11):3930-6.
3
Surface-bound capsular polysaccharide of type Ia group B Streptococcus mediates C1 binding and activation of the classic complement pathway.Ia型B族链球菌的表面结合荚膜多糖介导C1结合和经典补体途径的激活。
J Immunol. 1986 Jun 1;136(11):4157-62.
4
Spontaneous activation of serum C1 in vitro. Role of C1 inhibitor.
J Immunol. 1991 Sep 15;147(6):1884-90.
5
C1q and C4b bind simultaneously to CR1 and additively support erythrocyte adhesion.C1q和C4b同时与CR1结合，并累加性地支持红细胞黏附。
J Immunol. 1999 Nov 1;163(9):5056-63.
6
The classical complement pathway: mechanism of activation of the first component by antigen-antibody complexes.经典补体途径：抗原-抗体复合物激活第一成分的机制。
Prog Allergy. 1982;30:135-92.
7
Spontaneous activation of reconstituted and serum C1 and the role of C1-inhibitor.
Behring Inst Mitt. 1989 Jul(84):102-10.
8
The effect of specific antibody on antibody-independent interactions between E. coli J5 and human complement.特异性抗体对大肠杆菌J5与人补体之间非抗体依赖性相互作用的影响。
J Immunol. 1982 Feb;128(2):707-11.
9
The critical concentration of C1-esterase inhibitor (C1-INH) in human serum preventing auto-activation of the first component of complement (C1).
Mol Immunol. 2005 Apr;42(6):657-63. doi: 10.1016/j.molimm.2004.09.025. Epub 2004 Nov 23.
10
Binding and activation of the first complement component by soluble immune complexes: effect of complex size and composition.可溶性免疫复合物对补体第一成分的结合与激活：复合物大小和组成的影响
Scand J Immunol. 1984 Feb;19(2):99-110. doi: 10.1111/j.1365-3083.1984.tb00905.x.

引用本文的文献

1
The Crystal Structure of the Michaelis-Menten Complex of C1 Esterase Inhibitor and C1s Reveals Novel Insights into Complement Regulation.C1 酯酶抑制剂与 C1s 的米氏复合体的晶体结构揭示了补体调控的新见解。
J Immunol. 2024 Sep 1;213(5):718-729. doi: 10.4049/jimmunol.2400194.
2
A Novel Porcine Model of Ischemia-Reperfusion Injury After Cross-Clamping the Thoracic Aorta Revealed Substantial Cardiopulmonary, Thromboinflammatory and Biochemical Changes Without Effect of C1-Inhibitor Treatment.一种新的猪模型揭示了主动脉夹闭后的缺血再灌注损伤，表现出明显的心肺、血栓炎症和生化变化，而 C1 抑制剂治疗无效。
Front Immunol. 2022 Apr 1;13:852119. doi: 10.3389/fimmu.2022.852119. eCollection 2022.
3
Complement Activation in the Central Nervous System: A Biophysical Model for Immune Dysregulation in the Disease State.
中枢神经系统中的补体激活：疾病状态下免疫失调的生物物理模型。
Front Mol Neurosci. 2021 Mar 4;14:620090. doi: 10.3389/fnmol.2021.620090. eCollection 2021.
4
Biomarkers in Hereditary Angioedema.遗传性血管性水肿的生物标志物。
Clin Rev Allergy Immunol. 2021 Jun;60(3):404-415. doi: 10.1007/s12016-021-08845-6. Epub 2021 Feb 9.
5
The interaction between the complement system and hemostatic factors.补体系统与止血因子的相互作用。
Curr Opin Hematol. 2020 Sep;27(5):341-352. doi: 10.1097/MOH.0000000000000605.
6
Mutations Trigger Constitutive Complement 1 Activation in Periodontal Ehlers-Danlos Syndrome.突变触发牙周型埃勒斯-当洛斯综合征中补体 1 的持续激活。
Front Immunol. 2019 Nov 5;10:2537. doi: 10.3389/fimmu.2019.02537. eCollection 2019.
7
A New Tool for Complement Research: Reconstituted Human Classical Complement Pathway.补体研究的新工具：重建人经典补体途径。
Front Immunol. 2018 Dec 4;9:2770. doi: 10.3389/fimmu.2018.02770. eCollection 2018.
8
Dual inhibition of complement and Toll-like receptors as a novel approach to treat inflammatory diseases-C3 or C5 emerge together with CD14 as promising targets.补体和Toll样受体的双重抑制作为治疗炎症性疾病的新方法——C3或C5与CD14一起成为有前景的靶点。
J Leukoc Biol. 2017 Jan;101(1):193-204. doi: 10.1189/jlb.3VMR0316-132R. Epub 2016 Aug 31.
9
Complement System Part I - Molecular Mechanisms of Activation and Regulation.补体系统 第一部分——激活与调节的分子机制
Front Immunol. 2015 Jun 2;6:262. doi: 10.3389/fimmu.2015.00262. eCollection 2015.
10
C1-inhibitor efficiently inhibits Escherichia coli-induced tissue factor mRNA up-regulation, monocyte tissue factor expression and coagulation activation in human whole blood.C1 抑制剂能有效抑制大肠埃希菌诱导的人全血组织因子 mRNA 上调、单核细胞组织因子表达和凝血激活。
Clin Exp Immunol. 2013 Aug;173(2):217-29. doi: 10.1111/cei.12098.